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Abstract
Paramecium, a unicellular ciliate, can be attracted by various chemical stimuli.
Chemoattractants such as glutamate, folate, cAMP, and acetate activate different
receptor mediated signal transduction pathways. The final event in these signal
transductions is a hyperpolarization of membrane potential, which makes
Paramecium swim smoothly and fast. There is evidence that the effecter of this
hyperpolarization is the plasma membrane calcium ATPase (PMCA), that when
activated, expels Ca2+ from the cell. In Paramecium three PMCA isoforms,
named PMCA2, 3, and 4, have been cloned. PMCA2 is associated with lipid rafts,
which is demonstrated by its resistance to cold detergent solubilization and
distribution in sucrose density gradients in ultracentrifugation. PMCA3 and 4 are
not associated with lipid rafts. On the cell surface, PMCAs are localized to the
bases of cilia. Sterol-depletion by methyl-ß-cyclodextrin (MßCD) treatment
disrupts the distribution of PMCA2 in sucrose density gradients and ciliary baselocalization on the cell surface. MßCD treatment also decreases the
chemoattraction to glutamate and cAMP. This indicates that PMCA2 and its
association with lipid rafts are essential in the chemoattraction signal
transduction pathways. Based on these results, a model of membrane domains
incorporating three signal transduction pathways is proposed.
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Chapter 1

Comprehensive Literature Review

1

I. Paramecium
A. General introduction of Paramecium
Paramecium is a unicellular ciliated Protozoa, living in fresh water.
Paramecium employs both typical eukaryotic organelles such as mitochondria,
ribosome, endoplasmic reticulum, Golgi apparatus, an endocytic system and
lysosome system, and nuclear systems and some specialized structures such as
the contractile vacuole complexes, the alveolar system, the trichocysts, the
buccal cavity and the cytoproct in growth, metabolism, catabolism and
reproduction to maintain life (Allen, 1988).
The life cycle of Paramecium consists of both asexual phase, binary fission,
and sexual phase, conjugation and autogamy (Vivier, 1974).
Paramecium is 80 m - 350 m in length and 40 m - 80 m in width
according to species (Vivier, 1974). The cell body is coated with 5000-6000 cilia
(Preston and Saimi, 1990), each of which is covered by a membrane. Although
the ciliary membranes and the somatic membranes are physically continuous,
the molecular components and biochemical composition are different, which
reflects the specialized functions of these two surfaces (Allen, 1988). The cilia
have important roles in the life of Paramecium due to their responsibilities for
locomotion in water, ingestion of food and conjugation.
Like other ciliates, Paramecium has a dual nuclear system. There is one
larger macronucleus and variable number of small micronuclei. They share a
common cytoplasm. Only the macronucleus is active during transcription and
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essential for the survival and reproduction of the cell. It contains genomic DNA,
produces both ribosomal RNA and messenger RNA for protein synthesis, and
governs the cytoplasmic and nuclear physical activities. The micronucleus serves
as a germinal nucleus, which generate gametic nuclei to form zygotic nucleus
after conjugation (Mikami, 1988).
Paramecium uses TGA as a stop codon in protein translation, and the
other two universal stop codons TAA and TAG encode glutamine or glutamic
acid respectively (Freiburg, 1988).
One special property of Paramecium is that it contains an excitable
membrane that can be depolarized and hyperpolarized. The change in
membrane potential results in observable changes of Paramecium swimming
pattern. When the cell membrane is depolarized to threshold, an action potential
occurs. Consequently, Paramecium swims backward transiently during the
depolarization. After repolarization the cell swims forward again in a new
direction. When the cell membrane is hyperpolarized, the Paramecium swims
fast and smoothly with few turns (Preston and Saimi, 1990).
Another property of Paramecium is chemosensory response. Paramecium
is capable to detect changes in a variable environment including chemicals,
temperature, pH, ionic composition and food (bacteria). When Paramecium
senses harmful chemicals, unfavorable ion concentration, or extreme pH
condition, it swims backward for a short distance, followed by swimming forward
again in a new direction. This response is called chemorepulsion. When the
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Paramecium senses bacterial metabolites such as glutamate, folate or acetate
that signal its food source, it increases swimming speed toward these chemicals.
This response is called chemoattraction (Van Houten, 1998). Chemical stimuli
resulting in repulsion or attraction of Paramecium are based on changing the
membrane potential of the cell. During chemorepulsion, membrane potential is
depolarized; and during the chemoattraction, is hyperpolarized.

B. Membrane Potential and Swimming Behavior
Paramecium lives in fresh water. In the laboratory, the condition of fresh
water with low ion concentration is mimicked by a solution containing 1 mM K+
and 1 mM Ca2+, resulting in a resting membrane potential of –30 to –40 mV
(Machemer, 1988). The resting membrane potential of Paramecium is
maintained through two essential ion concentration batteries, Ca2+ and K+. Ca2+
has an inward-directed concentration gradient making for Ca2+ influx. K+ has an
outward-directed concentration making for K+ efflux (Machemer, 1988). Any
changes of Ca2+ or K+ in extracellular milieu cause a dramatic and direct effect on
the resting membrane potential and upon then swimming behavior.
The membrane potential controls the activity of ion conductance and
enzymes in the cilia, which finally determine the patterns of ciliary beating. The
swimming behavior of Paramecium depends on two characteristic elements of
cilia: the beating frequency and the beating direction. The membrane potential
can affect them both.
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When the membrane potential undergoes a sufficient depolarization in
response to certain cations, mechanical stimulation or organic repellent, a Ca2+
action potential is triggered resulting from activation of voltage-gated Ca2+
channels that are localized in the ciliary membrane (Preston and Saimi, 1990).
Ca2+ enters the cell through voltage-gated Ca2+ channels to increase the internal
free Ca2+ from10-8 M to 10-6 M (Wright, 1990). The increase of Ca2+ causes the
axoneme to beat more rapidly in reverse direction, but the mechanism is still
unknown (Preston and Saimi, 1990). Consequently, Paramecium swims
backward. This voltage-gated Ca2+ channel in Paramecium shares the similarity
with those in higher organisms in that it can be inactivated by the influxed Ca 2+.
But it is sensitive to an anticalmodullin agent, W-7 [N-(6 aminohexyl)-5-chloro-1naphthalenesulphonamide] that inhibits the voltage-gated Ca2+ current reversibly
as well as backward swimming (Hennessey and Kung, 1984). The duration of
depolarization and backward swimming is normally transient. After each action
potential, the cell will be repolarized by K+ conductance through voltage-gated K+
channels, and the increased Ca2+ will be removed. The membrane potential
returns to the resting level and Paramecium swims forward again. If the
depolarization-triggered Ca2+ action potential occurs in Na+-containing medium,
the depolarization will be prolonged by the influx of Na+ through the Ca2+dependent Na+ channels, which leads a longer backward swimming. This results
in the activation of Ca2+-dependent K+ channels that also make a contribution in
the repolarization of the membrane potential (Ramanathan et al., 1988).
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Paramecium also responds to the hyperpolarization of membrane potential.
As a result of hyperpolarization of membrane potential resulting from a K + efflux,
the cilia beat more frequently in a posterior direction and the cell swims forward
fast and smoothly with few turns. Hyperpolarization activates voltage-gated K+
channels (Preston and Saimi, 1990). The biochemical consequence of
hyperpolarizing membrane potential is the activation of adenylyl cyclase and the
increase of the concentration of intraciliary cAMP, which stimulates cAMPdependent protein kinases to phosphorylate a number of ciliary proteins (Bonini
et al., 1986). With these phosphorylated ciliary proteins, the cilia beat with
increased frequency in a more posterior direction, and the cell swims forward
faster. During chemoattraction, Paramecium exhibits the hyperpolarization of
membrane potential.

C. Chemoattraction of Paramecium
Paramecium can be attracted by different types of chemical stimuli.
Chemicals such as acetate, biotin, cyclic AMP, folate, glutamate, and NH4Cl are
known as chemoattractants of Paramecium. These chemoattractants are
bacterial metabolites, which signal the food source of Paramecium. It is proposed
that there are three signal transduction pathways for chemoattractants, all of
which can lead to hyperpolarization of membrane potential and change in
swimming pattern (Van Houten, 1998). These three signal transduction pathways
in chemoattraction are illustrated in figure A (Fig. A)
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In pathway 1, the attractants can be acetate, biotin, cyclic AMP or folate.
Through binding kinetics studies, behavioral studies and electrophysiology
studies, it is found that there are specific binding sites, namely receptors, on the
cell surface for each attractant (Sasner and Van Houten, 1989; Van Houten et al.,
1991; Bell et al., 1998). Recently, the genes of the cyclic AMP receptor and the
folate receptor in Paramecium have been cloned (Valentine et al., 2005).
Binding of each attractant to its receptors can lead Paramecium to hyperpolarize
8-10 mV (Van Houten, 2000). It is believed that a Ca2+ conductance generated
by the plasma membrane Ca2+ pump (PMCA) may contribute to this sustained
hyperpolarization. Neither Na+ nor K+ current is involved, because there is no
reversal potential or removal of Na+ or K+ from extracellular medium has no effect
on the attractant-induced hyperpolarization (Preston and Van Houten, 1987).
This result also excludes a Na+/Ca2+ exchanger to generate the Ca2+
conductance (Preston and Van Houten, 1987). It has been demonstrated that a
Ca2+ ATPase possesses all the peculiar PMCA properties in cell pellicle
membranes (Wright and Van Houten, 1990). Genes of three PMCA isoforms
have been cloned (Elwess and Van Houten, 1997; Gannon-Murakami, 2004).
There are two pieces of evidence to support the proposal that the Ca 2+
conductance is generated by the activation of PMCA to hyperpolarize membrane
potential during chemoattraction (Wright et al., 1992). First, Li+ can inhibit Ca2+
pump ATPase activity. Paramecium treated with 10 mM LiCl for 1 hour shows
decreased rate of Ca2+ efflux (Wright et al., 1992). Li+ treatment also disrupts the

7

chemoattraction to acetate, cyclic AMP, or folate (Wright et al., 1992). Second, a
mutant of Paramecium, K-shy, has a defective Ca2+ extrusion mechanism (Evans
et al., 1987) is not attracted by the same attractants (Wright et al., 1992).
However, second messengers such as cAMP, cGMP or IP3 have been not
identified in this pathway. The mechanism of coupling receptors to Ca2+ pumps is
still unknown.
In pathway 2, the chemoattractant is glutamate. The glutamate
chemoreceptor has been characterized through binding assays and behavioral
studies (Yang, 1995). The glutamate receptor gene has been cloned (Jacobs,
2007). After glutamate binds to a surface receptor, a transient K+ conductance
and sustained hyperpolarization are observed (Preston and Usherwood, 1988).
Additionally, the intracellular cAMP level increases by 3-fold in 30 milliseconds
and by 7-fold in 150 milliseconds (Yang, 1997). One K+ channel in Paramecium
is associated with an adenylyl cyclase, which converts ATP to cAMP (Shultz et
al., 1992). A mutant of Paramecium, restless, which is oversensitive to low
extracellular K+ and lacks control of K+ resting conductance, has a defect in
cAMP formation (Saimi and Kung, 1987; Shultz et al., 1992). These results
indicate that a hyperpolarization-activated K+ conductance directly regulates the
cAMP formation in Paramecium. It is possible that the increased cAMP activates
cAMP-dependent protein kinases (PKA), which is known to activate the PMCA in
mammalian system (James, 1989). The existence of PKA in Paramecium has
been proven (Hochstrasser and Nelson, 1989). In Paramecium there is no direct
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evidence that PKA phosphorylates the PMCA in vivo. However, addition of cAMP
or PKA increases the Ca2+ ATPase activity on cell membrane preparations (Yang,
1997). The calmodulin-binding domains (CBD) in Paramecium PMCAs are
substrates of PKA in vitro (Gannon-Murakami, 2004). Furthermore, the general
kinase inhibitors H7 and H8 were shown to disrupt the chemoattraction to
glutamate (Yang, 1997). All these results strongly indicate that glutamate signals
by increasing the intracellular cAMP and activating PKA, which phosphorylates
the CBDs of PMCA and activates the Ca2+ pump to generate a sustained
hyperpolarization conductance by extruding Ca2+.
In pathway 3, the only identified stimulus is NH4Cl. No receptor is required
in this pathway. NH4Cl can be equilibrated with NH3 to diffuse across the
membrane and rapidly alkalinize the inside of cells, which can be monitored by
using a sensitive fluorescent dye (Davis et al., 1998). It is proposed that the
hyperpolarization in this pathway results from the activation of a pH sensitive
cation channel to generate the hyperpolarization conductance (Van Houten,
1998).
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II. Plasma Membrane Ca2+ ATPase
A. General properties of PMCA
Plasma membrane Ca2+-ATPases (PMCAs or Ca2+ pumps) are well
characterized Ca2+ expulsion system in eukaryotic cells. Working along with
Na/Ca exchangers, PMCAs extrude from the cell the elevated intracellular Ca 2+
that occured during Ca2+ signaling. Due to the high affinity for Ca2+ (the Km can
be 0.2 M at the activated state), PMCAs can interact with Ca2+ at very low
concentration, which makes PMCAs responsible for continuous and accurate
regulation of intracellular Ca2+ and maintenance of Ca2+ homeostasis (Carafoli,
1991a and b).
PMCA is a member of the P-type family of ion-transporting ATPases,
which are attributed by the formation of a phosphoenzyme intermediate during
the reaction cycle. The mechanism of Ca2+ transport by PMCAs is illustrated in
figure B (Fig. B). In the presence of Ca2+, an aspartic acid residue in PMCA will
be phosphorylated by ATP to form the aspartyl phosphate intermediate. This
reaction can be accelerated by the presence of Mg2+. There are two conformers
of the PMCA intermediate that are termed as E1 (Ca2+ Bound) and E2 (Ca2+ free)
in the catalytic reaction cycle. In the state of E1, the Ca2+ binding site is toward
the cytosolic side; in the state of E2 that is toward the extracellular side. The
translocation of Ca2+ across the plasma membrane is correlated to the
conformational transition from the high-energy form E1~P to the low-energy form
E2-P. The stoichiomitry of Ca/ATP per reaction cycle is one. There are two
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classic inhibitors of PMCAs. La3+ inhibits PMCAs by stabilizing the
phosphoenzyme resulting from inhibiting the hydrolysis of aspartyl phosphate.
Vanadate inhibits PMCA by blocking the formation of the aspartyl phosphate
(Jencks, 1989; Carafoli, 1991a and b; Stokes, 2003).
PMCAs consist of 10 transmembrane domains (TM1-TM10) (Wang,
1992). Both NH2-terminus and COOH-terminus are in the cytosol. Connecting
TM2 and TM3 is the first intracellular loop, called an actuator domain, which
contains one acidic phospholipid sensitive region. The second intracellular loop,
containing the catalytic domain, connects TM4 and TM5, which include the
aspartyl phosphate site (aspartic acid residue), and the ATP binding site (lysine
residue) (Wang, 1992; Monteith, 1995; Penniston, 1998). Most of the regulatory
domains reside in the region between TM10 and COOH-terminus, which includes
calmoduling binding domain, protein kinase activating sites, PDZ binding
domains and protease cleavage sites (Carafoli, 1994; Strehler, 2001).
PMCAs are encoded by 4 separate genes in mammalian systems. Four
major PMCA isoforms (PMCA1-4) are expressed in cells (Monteith, 1995;
Strehler, 2001). PMCA1 and PMCA4 are widely expressed in most adult tissues;
however, PMCA2 and PMCA3 have a limited tissue distribution. PMCA2 is
predominantly expressed in brain and lactating mammary glands (Strehler, 2004).
The expression of PMCA3 is abundant in rat skeletal muscles. Extra PMCA
variants are generated through alternative mRNA splicing of the 4 primary PMCA
isoforms. There are two splicing sites in the PMCA gene transcript. One (splicing
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site A) is located in the first cytosolic loop, just before the acidic phosphoslipid
activating site; the other (splicing site C) is in the calmodulin binding domain
(Strehler, 2001).

B. Regulation of PMCA
As an intracellular Ca2+ tuner, being essential in exporting the increased
Ca2+ and maintaining the low resting level of intracellular Ca2+, PMCAs are
multifariously regulated in vivo. Different methods of regulating PMCAs include
interactions with calmodulin, phospholipids, protein kinases, G-proteins,
oligomerization and localization in lipid rafts (Wang et al., 1992; Carafoli, 1994;
Monteith, 1995).
a. Activation by Calmodulin
The activation of PMCA by calmodulin has been comprehensively
studied. In the inactive state, PMCA is autoinhibited by the interaction between
the calmodulin binding domain and two regions in actuator and catalytic domains
respectively (Enyedi1989; Falchetto, 1991; Falchetto et al., 1992). Due to the
blockade of COOH-terminal domain at the catalytic domain in the second
intracellular loop, the catalytic reaction cannot occur. When calmodulin binds to
the COOH-terminal autoinhibitory domain, the intramolecular interaction is
dissociated and the autoinhibition is released resulting in the active state of
PMCA (Carafoli, 1992; Strehler 2001). The interaction with calmodulin increases
Ca2+ affinity, which deceases Km of Ca2+ from 10-20 M to 0.4-0.7 M, and raises
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the maximum velocity (Vmax) of the catalytic reaction by tenfold (Wang, 1992;
Carafoli, 1994).
One alternative splicing site resides in the calmodulin binding domain.
The alternative splicing affects the activation of PMCA by calmodulin (Strehler
2001). The calmodulin sensitivity of PMCA is isoform-dependent. PMCA2a
shows the highest affinity of calmodulin whose dissociation constant (K d) is ~2
nM (Elwess et al., 1997). Among PMCA4 isoforms, the Kd of isoform 4b is 7.6 nM
and that of isoform 4a is 125 nM (Enyedi, 1994; Caride et al., 1999).
b. Activation by acidic phospholipids
Besides the activation by calmodulin, PMCA can be stimulated by acidic
phospholipids (APL), particularly phosphotidylinositol 4-phosphate and
phosphotidylserine, and long-chain polyunsaturated fatty acids such as oleic
acids (Carafoli, 1991a and b; Wang, 1992; Monteith, 1995). There are two acidic
phospholipid binding regions in PMCA. One is located at the splicing site A in the
actuator domain; the other is located at the splicing site C in the calmodulin
binding domain (Brodin et al., 1992; Filoteo et al., 1992). The binding of APL to
the calmodulin binding domain can make PMCA insensitive to calmodulin
(Enyedi, 1987). The activation is like the activation by calmodulin increasing the
Vmax by releasing the autoinhibition. The activation by APL in the actuator domain
is calmodulin-independent, which can further activate PMCA by decreasing the
Kd of calmodulin activated PMCA from 0.4 μM to 0.2 M (Wang, 1992; Monteith
1995; Strehler 2001).
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c. Regulation by protein kinases
PMCA can be activated by cAMP-dependent protein kinase (PKA)
(Caroni, 1981). In vitro, PKA phosphorylates a serine that is located between
calmodulin binding domain and COOH-terminus. The phosphorylation by PKA
can reduce the Km of the purified PMCA from 10 M to 1.4 M and raise the Vmax
about twofold (James, 1989).
Protein kinase C can also phosphorylate PMCA (Smallwood, 1988).
Threonine and serine residues from both calmodulin binding domain and its
downstream region are the targets of the PKC (Wang et al., 1991; Enyedi, 1996).
Phosphorylation within calmodulin binding domain reduces the binding of
calmodulin. However, the downstream phosphorylation has no interference with
calmodulin binding, which partially activate PMCA by increasing the Vmax of
PMCA (Hofmann, 1994; Monteith, 1995). Tyrosine phosphorylation is also found
on PMCA in human platelets. But this phosphorylation down-regulates PMCA
activity (Dean, 1997).
d. Regulation by G-proteins
In liver cells, PMCA activity is indirectly regulated by G-proteins (Monteith,
1995). All the data suggests that the G-protein regulation results in inhibition of
PMCA activity. PMCA can be inhibited by several hormones such as miniglucagon, calitonin and human parathyroid hormone (Jouneaux, 1994). Gprotein βγ subunits increase the glucagon-sensitivity of PMCA resulting in
inhibition of the basal activity of PMCA (Lotersztajn, 1992). In addition, Gsα

14

subunit can transduce the signal of hormonal inhibition to PMCA (Jouneaux,
1993). Another G-protein regulated inhibition of PMCA results from the Gprotein activated phopholipase C (PLC). PLC hydrolyzes phosphotidylinositol
4,5 biphosphate (PIP2) which can partially activate PMCA (Monteith,1995;
Strehler 1995).
e. Regulation by oligomerization
PMCA can be activated by oligomerization (Kosk-Kosicka, 1988). The
self-association (dimerization) of PMCA is mediated through the calmodulinbinding domain. When the concentration of PMCA reaches 25 nM, the
activation of PMCA is calmodulin-independent (Kosk-Koska, 1989; Wang, 1992;
Monteith, 1995). A Ca2+-dependent protease, calpain, can truncate the
calmodulin domain in PMCA, resulting in a constitutively active form of PMCA.
This truncated PMCA cannot form the dimer any longer (Vorherr, 1991).
f. Localization in lipid rafts
PMCA was first found localized in caveolae (Fujimoto, 1993), a subtype
of lipid rafts. In proximal kidney tubules, the activation of PMCA is dependent on
the exclusive localization of PMCA in caveolae (Tortelote, 2004). Recently, in
primary cultured neurons, PMCA was localized in lipid rafts (Sepulveda, 2006).
The localization in lipid rafts raises the total PMCA activity compared with the
non-raft PMCAs. Raft-disruption by cholesterol depletion can reduce the raftassociated PMCA activity (Jiang, 2007). All these results indicate that the
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localization in lipid rafts can be a new regulatory mechanism of PMCA activity
and further intracellular Ca2+ signaling.

C. Protein-protein interactions of PMCA
Protein-protein interactions of PMCA have been studied extensively. The
b splicing isoforms of PMCA contain PDZ (PSD-95/Dlg/ZO-1)-binding domain at
COOH-terminus that can interact with PDZ-domain containing proteins (Strehler,
2001). A few protein interaction partners of PMCAS have been identified such as
nitric oxide synthase I (NSO I) (Schuh, 2001), Na+/H+ exchanger regulatory factor
2 (NHERF2) (DeMarco, 2002), cytoskeleton (Zabe, 2001), Ca2+/calmodulin –
dependent membrane associated kinase (CASK) (Schuch, 2003) and
membrane-associated guanylate kinase (MAGUK) (Kim, 1998; DeMarco, 2001).
The interaction of PMCA with NSO I or NHERF 2 may provide cross-talk
between Ca2+ signaling and other cellular signal transductions. While the
interaction with cytoskeleton, CASK, or MAGUK can recruit PMCA in a specific
domain in plasma membrane to regulate the local Ca2+ signaling in a
microenvironment.
In addition to PDZ-binding domain at COOH-terminus, other domains in
PMCA also participate in protein interactions. The catalytic domain in the second
intracellular loop of PMCA4b interacts with tumor suppressor RAS-associated
Factor 1(Armesilla, 2004). This interaction indicates that PMCA may be involved
Ca2+ regulation in apoptosis signaling. Another protein interaction domain in
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PMCA is NH2-terminus of PMCA4, which interacts with 14-3-3 ε protein. This
interaction inhibits PMCA activity (Rimessi, 2005).

D. PMCA in Paramecium
PMCA activity was first biochemically characterized in Paramecium. In
the presence of Mg2+, the Km of Ca2+ is 90 nM (Wright, 1990). Three PMCA
isoforms (2-4) have been cloned, and 20 more were found in annotated
Paramecium genome (Genoscope).The calculated molecular weight of the three
cloned PMCA isoforms (2-4) are listed in table A (table A). Paramecium PMCAs
share the characteristic properties with the counterparts in mammalian cells.
However, Paramecium PMCAs contain a shorter calmodulin domain (16 amino
acids) compared with that (28 amino acids) of mammalian PMCAs (Elwess, 1997;
Penniston, 1998). The protein sequences of calmodulin-binding domain (CBD)
from PMCA2, 3 and 4 show a very high homology. Their alignment is showed in
table B (Table B). Two serines from calmodulin-binding domain of Paramecium
PMCAs can be phosphorylated by PKA and PKC in vitro (Gannon-Murakami,
2004). An antibody has been generated against the CBD form PMCA2, which is
referred to as anti-CBD. Since the CBDs show high homology among PMCA
isoforms, several CBDs from different PMCA isoforms were tested to determine
whether these CBDs can be recognized by anti-CBD in Western Blot. It has be
found that CBDs from PMCA2, 3,4,18 and possibly 19 (PMCA18 and 19 have the
same protein sequence of CBD) can be recognized by anti-CBD. The results are
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summarized in table C (table C). Based on the putative amino acid sequence, the
PMCA protein structure is developed (Fig. C).The PMCAs may be involved in
chemoattraction in Paramecium by regulating Ca2+ efflux to generate the
attractant-stimulated hyperpolarization. It has been found that PMCA2
overexpression leads to defective Ca2+ homeostasis and a defective
chemoattraction to folate. PMCA3 overexpression results in not only the
defective Ca2+ homeostasis, but also a significant disruption in chemoattraction
to glutamate, acetate and folate (Dr. Yano, personal communication). All these
results implicate PMCAs as an important element in the chemoattraction in
Paramecium.
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III. Lipid Rafts
A. General concept of lipid rafts
Lipid rafts are small and specialized domains in cell membranes. The
size of lipid rafts varies in studies using different biochemical and biophysical
method, but the generally accepted size is 10-200 nm (Pike, 2006). Lipid rafts
are compositionally heterogeneous. Lipid rafts contain high levels of saturated
fatty acids, sterol, and sphingolipids. The extended saturated fatty acid chain and
intercalated cholesterol make membranes a tightly packed structure in liquidorder phase compared to membranes filled with unsaturated fatty acid chain that
are more fluid and liquid-disordered (Simons, 1997; Zurzolo, 2003; Munro, 2003).
This special composition and structure of lipids makes lipid rafts resistant to
detergent (Triton X-100) solubilization at 4°C (Simons, 1997). Lipid rafts are also
referred to as detergent-resistant membrane (DRM) (Munro, 2003). The
traditional method to recover lipid rafts is floatation of lipid rafts in a 5% to 40%
linear sucrose density gradient through ultracentrifugation (Brown, 1992).
There is a specialized subtype of cholesterol-enriched lipid rafts, which
forms ―flask shaped‖ invaginations of membranes. These invaginated lipid rafts
are termed caveolae (Simon, 1997; Anderson, 1998). The formation of caveolae
is due to the self-association of caveolin that is a cholesterol-bound and acylated
integral membrane protein (Simons, 1997).
Since cholesterol is the essential component of lipid rafts, any
manipulation of content of cholesterol in membrane can affect the formation and
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function of lipid rafts (Zajchowski, 2002). In studies, methyl-β-cyctodextrin (MβCD)
that depletes cholesterol from membrane is a widely used drug to reduce the
cholesterol level in membrane, which consequently disrupts lipid rafts
(Zajchowski, 2002, Wang, 2006). MβCD is a cyclic oligosaccharide containing 7
glucopyranose units. MβCD works like a cholesterol chelator, which binds
cholesterol and sequesters them out of membrane (Zidovetzki, 2007).
In addition to caveolin, there are different types of proteins that are
preferentially associated with lipid rafts. The exemplary raft-associated proteins
target into lipid rafts through various mechanisms. Some raft-associated proteins
partition into lipid rafts through protein-lipid interaction, like hedgehog
(cholesterol-bound), and annexin (phospholipids-bound) (Rajendran, 2005; Wang,
2006). Others through different post-translational modifications like folate
receptors (glycosylphosphotidylinosito (GPI)-anchored), Src-family tyrosine
kinases (dually acylated), flotillin (palmitoylated and myristoylated). These
proteins can be used as markers for lipid rafts (Rajendran, 2005; Wang, 2006).
Lipid rafts can be associated with cytoskeleton proteins (Ikonen, 2001),
which brings a new concept of lipid rafts. Lipid rafts float in top fractions in the
linear sucrose density gradient due to their lighter density. When lipid rafts are
associated cytoskeleton, lipid rafts show high buoyant density and float in the
bottom fractions with high dense sucrose gradient (Nebal, 2002). These
cytoskeleton-attached lipid rafts are referred as DRM with high buoyant density
(DRM-H). Cytoskeleton protein F-actin and other scaffold proteins, such as fodrin,
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α-actinin, vimentin, and supervillin, form a complex of membrane skeleton
structure beneath lipid rafts, referred as membrane skeleton (Luna, 2005).
Lipid rafts are temporally and spatially dynamic (Pike, 2006). The
formation of lipid rafts is mediated by the interactions between the incorporated
lipids and proteins to cope with the cellular physiological activities.

B. Function of lipid rafts
Lipid rafts play roles in various cellular physiological activities. One of
the essential and relatively well established roles of lipid rafts is mediating
receptor-coupled signal transductions in cells, such as growth factor receptors,
G-coupled receptors, and immune receptors (Zajchowski, 2002).
Several growth factor receptors have been demonstrated to have their
signaling correlated with lipid rafts. Insulin receptor is preferentially localized in
caveolae. Non-raft-associated insulin receptor will also be translocated in
caveolae after ligand (insulin) stimulation (binding) (Pike, 2005). NGF receptors
are also highly concentrated in caveolae, but their caveola-localization is
constitutive and independent on ligand binding (Pike, 2003). EGF receptors and
PDGF receptors are originally localized in lipid rafts. After the ligand binding,
these receptors will be excluded from lipid rafts, and undergo endocytosis
through clathrin-coated pits (Zajchowski, 2002). Together with receptors,
signaling effectors such as Src-family kinases, adaptor proteins, MAP Kinases
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are also recruited in lipid rafts to fulfill the signal transduction (Simons, 2000; Pike,
2005).
A great number of G protein-coupled receptors (GPCR) such as
acetylcholine receptor, adrenergic receptor, dopamine receptor, Neurokinun
receptor, purinergic receptor and serotonin receptor have been shown to
localized in lipid rafts by anatomical and biochemical methods (Pike, 2003; Allen,
2006). After ligand stimulation, their translocation into lipid rafts make them
readily interact with G proteins, Gαs, Gαq, Gβγ, and G-protein effectors, adenylyl
cyclase and phopholipase C, which are concentrated in lipid rafts as well (Allen,
2006).
Lipid rafts are also involved in immune receptor signaling (Zajchowski,
2002). The typical example is B-cell receptor (BCR), whose translocation into
lipid rafts is ligand (antigen) mediated. In the resting B-cells, individual BCR
reside outside of lipid rafts. Once cross-linked by antigens, the oligomerized BCR
will be translocated into lipid rafts, where they are phosphorylated by raftassociated Src-family kinase Lyn, commencing the signaling transduction.
Furthermore, the separated lipid rafts with the activated BCRs will aggregate with
the aid of cytoskeleton to form immune synapse in B-cells (Pierce, 2002). Other
immune receptor signaling like T-cell receptor (TCR) and IgE receptor are similar
to BCR signaling carried on in lipid rafts (Simons, 2000).
In summary, in signal transduction, lipid rafts serve as platforms that
recruit receptors and effectors into a favorable condition to readily interact with
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each other and efficiently transducer signals. By incorporating and excluding
receptors and effectors, lipid rafts can temporally and spatially monitor signal
transductions in a precise manner.
Lipid rafts are involved in membrane transport (Ikonen, 2001). Some
proteins are endocytosed through translocation into lipid rafts (Parton, 2003). The
endocytosis of cross-linked GPI-anchored proteins is carried on by internalization
of caveolae other than clathrin-coated pits (Rajendran, 2005). EGF receptors and
PDGF receptors first move out of lipid rafts after ligand binding (stimulation), then
internalized in clathrin-coated pits (Zajchowski, 2002). Lipid rafts serve as a
switch to turn off (down-regulating) EGF receptor and PDGF receptor signaling.
Lipid rafts also mediate protein sorting. In the ER system and Golgi apparatus,
raft structures are identified (Helms, 2004). In polarized epithelial cells, the
association of apical GPI-anchored proteins with lipid rafts starts in the Golgi
apparatus (Simons, 1997). The same sorting of GPI-anchored proteins in yeast
happens in ER (Ikonen, 2001).
Lipid rafts may also be involved in governing the membrane potential
and Ca2+ homeostasis. Voltage gated K+ channel (Kv1.5) is localized in caveolae.
Kv1.5 is a substrate of Src-family tyrosine kinases. Phosphorylation decreases its
conductance (Marten, 2004). In addition, PMCA, Na/Ca exchange I (NCX I), and
voltage-dependent Ca2+ channels are co-localized in caveolae in smooth muscle.
It is proposed that caveolae with Ca2+ handling proteins work along with
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peripheral Ca2+ store (sacroplasmic reticulum) to control local Ca2+ concentration
(Daniel, 2006).

C. Lipid rafts in Paramecium
A model of lipid rafts has been characterized by biochemical criteria
(Chandran, 2004). Paramecium lipid rafts share the general raft-properties: (i)
they are resistant to cold, non-ionic detergent (Triton X-100) extraction, and (ii)
enriched with cholesterol, glycosphingolipids, and GPI-anchored proteins
(Chandran, 2004). In this model, it is proposed that lipid rafts are organized into
two types according to the different buoyant densities in sucrose or Optiprep
gradients. Ganglioside Gm, CaM-binding membrane-bound proteins and GPIanchored surface antigens are the main components in the light-density lipid rafts.
High-density lipid rafts are enriched with GPI-anchored folate binding proteins
and PMCAs as well as GPI-anchored surface antigens (Chandran, 2004). Lipid
rafts in Paramecium may be involved in chemosensory signal transductions.
Depletion of cholesterol by MβCD can disrupt the chemoattraction to glutamate
and folate. Lipid rafts may also serve as platforms to recruit receptors and downstream effectors in chemoattraction signal transductions.
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Figure A: The three proposed signal transduction pathways in
chemoattraction in Paramecium.
Pathway 1: The attractants can be acetate, biotin, folate, or cAMP. These
attractants bind to their specific receptors on the cell surface and activate PMCA.
The detail of this signal transduction pathway is still not clear.
Pathway 2: The attractant is glutamate. Glutamate binds to the glutamate
receptor on the cell surface, which activates a K+ conductance and adenylyl
cyclase. Adenylyl cyclase converts ATP to cAMP, which activates protein kinase
A (PKA). PKA activates PMCA by phosphorylation.
Pathway 3: The attractant is NH4Cl. It diffuses across the membrane. A pH
sensitive cation channel will be activated.
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Figure B: The reaction cycle of the plasma membrane Ca2+ ATPase.
In the state of E1, the Ca2+ binding site is toward the cytosolic side; in the state of
E2 that is toward the extracellular side. The translocation of Ca2+ across the
plasma membrane is correlated to the conformational transition from the highenergy form E1~P to the low-energy form E2-P.
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Figure C: The proposed protein structure of Paramecium PMCA.
1-10, transmembrane helices; D-- P, aspartate acylphosphate site; K, lysine ATP
binding site; P, proline hinge site. E (glutamate), N (aspargine) and D (aspartate)
in transmembrane domains form a Ca2+ binding site. CBD, calmodulin binding
site; SS, double serines phosphorylated by PKA and PKC in vitro.
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Table A: The calculated molecular weight of the three cloned PMCA
isoforms (2-4).
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Table B: The alignment of protein sequences of calmodulin-binding
domains (CBDs) from PMCA2, 3 and 4.
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Table C: Calmodulin-binding domains (CBDs) of different PMCA isoforms
can be recognized by anti-CBD. +: yes; -: no; ?: possibly.
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Project objectives
Hypothesis
In Paramecium, There are three signal transduction pathways involved in
chemoattraction, which have been described in detail in previous section (Fig. A).
In pathway 1 and 2, it is believed that the sustained membrane potential
hyperpolarization is due to the activation of PMCA, which generate the
hyperpolarizing conductance by extruding Ca2+ from cells during chemoattraction.
Based on the preliminary results, one hypothesis is developed: Paramecium
PMCA and its association with lipid rafts are essential in the chemoattraction
signal transduction.

Specific aims
This hypothesis is tested under 3 specific aims.
Specific aim 1
To identify the localization of PMCA on the cell surface membrane. The pellicle
proteins will be analyzed by Western Blot to demonstrate that PMCAs are
present in the pellicle. The localization of PMCA on the cell surface will be
determined by immunomicroscopy studies of Paramecium.

Specific aim 2
To determine the association of PMCA with lipid rafts in Paramecium. First, the
Triton X-100 solubility of pellicle proteins will be studied. Second, the Triton
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insoluble pellicle proteins will be analyzed by sucrose gradient ultracentrifugation
to demonstrate that PMCA is associated with lipid rafts. Third, the sterol in the
cell membrane will be decreased by methyl-β-cyclodextrin (MβCD) treatment.
Through the sterol-depletion, the lipid rafts will be disrupted in the cell membrane.
Fourth, the Triton-insoluble pellicle proteins from sterol-depleted cells will be
analyzed by sucrose gradient ultracentrifugation to study the effect of MβCD
treatment on the distribution of raft-associated proteins in sucrose gradients. In
addition, the effect of MβCD treatment on the localization of membrane proteins
will also be studied by immunomicroscopy.

Specific aim 3
To study the effect of PMCA down-regulation or raft-disruption on the
chemoattraction of Paramecium. PMCA will be down-regulated by RNAi feeding
method. The lipid rafts in Paramecium will be disrupted by MβCD treatment. The
chemoattraction of the PMCA down-regulated cells and the raft-disrupted cells
will be studied in T-maze assays.
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Chapter 2

The Role of Plasma Membrane Calcium ATPase (PMCA)
and its Localization in Lipid Rafts in Chemoattraction in
Paramecium
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Introduction
Paramecium tetraurelia is a unicellular ciliate. It can be attracted towards
different types of chemical stimuli, which are referred to as chemoattractants.
Usually, these attractants are bacterial metabolites, which indicate the food
source (bacteria). Chemoattractants can fall into three signal transduction
pathways. In pathway I, the only attractant is glutamate. In pathway II, the
attractants can be biotin, acetate, folate or cyclic AMP among others. In pathway
III, NH4Cl is the only one that has been identified (Van Houten, 1998). All these
three signal transduction pathways result in a hyperpolarization of membrane
potential in Paramecium. During hyperpolarization, cilia beat more frequently and
more directly toward posterior, making the cell forward swimming fast and
smooth (Preston and Saimi, 1990). In the chemoattraction signal transduction
pathway I and II, the signal transduction to membrane hyperpolarization is
receptor mediated. On the cell surface membrane, receptors of glutamate, cAMP,
folate, or biotin respectively have been characterized (Sasner and Van Houten,
1989; Van Houten et al., 1991; Bell et al., 1998). The effect of hyperpolarization
of membrane potential results from the activation of plasma membrane Ca 2+
ATPAse (PMCA), which generates a hyperpolarizing conductance by extruding
Ca2+ from the cell (Van Houten, 1998).

Three PMCA isoforms (named PMCA2-4) in Paramecium have been
cloned (Gannon-Murakami, 2004). Twenty more isoforms were found in the
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annotated Paramecium genome (Genoscope). Paramecium PMCA2-4 shares
the properties with mammalian counterparts (Wright, 1990; Elwess, 1997;
Gannon-Murakami, 2004).

Lipid rafts are particular microdomains in cell membranes, which are
recognized by enrichment of cholesterol, sphingolipids, and saturated fatty acids,
and resistance of cold detergent solubilization (Simons, 1997; Munro, 2003). One
critical role of lipid rafts in cellular physiological activities is serving as a platform
in signal transduction, which can recruit receptors and downstream effectors in a
relatively proximal distance to make signals transduce efficiently or exclude them
from rafts to terminate the signal transduction according to the physiological
necessity (Pike, 2003; Zajchowski, 2002). Lipid rafts can regulate signal
transductions in spatially and temporally precise manner. In Paramecium, lipid
rafts have been identified, which share the defining characteristics (Chandran,
2004).

PMCAs can be localized to lipid rafts. In kidney epithelial cells PMCA is
predominantly localized in caveolae. Its activity is caveola-dependent (Tortelote,
2004). In addition, PMCA can be selectively associated with lipid rafts. In primary
cortical neurons, the activity of PMCA is dependent on its localization into lipid
rafts. Raft-disruption through cholesterol depletion can reduce the activity of the
PMCA, but has no effect on that from outside of lipid rafts. The localization in lipid
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rafts provides a new regulatory mechanism to activate PMCA (Jiang, 2007). It
also implicates that lipid rafts may participate in the regulation of Ca2+ signaling
by incorporation of PMCA.

Here we report that in Paramecium, PMCA2, together with GPI-anchored
surface antigens and Paramecium calmodulin-binding membrane-bound proteins
(PCM) partition into lipid rafts. These proteins can be recovered by floatation in
sucrose density gradients through ultracentrifugation. Paramecium lipid rafts are
associated with cytoskeleton proteins such as tubulin and actin. In contrast,
PMCA3 and 4 are not localized in lipid rafts. On the cell surface membrane,
PMCAs are localized at the bases of cilia. Sterol depletion by Methyl-βcyclodextrim disrupts the distribution of PMCA2 in a sucrose density gradient and
the ciliary base-localization. In behavioral studies, the MβCD treated paramecia
show decreased chemoattraction to glutamate and cAMP. These results
implicate that PMCA and its association with lipid rafts play roles in
chemoattraction signal transduction. A revised model of 3 types of membrane
domains is proposed to explain the chemoattraction signal transduction in
Paramecium.
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Material and Methods
Cell Culture: Paramecium tetraurelia strain 51-s (sensitive to killer) was cultured
at 28 C in wheat grass (Pines, Lawrence, KS) medium (Sasner and Van Houten
1989) supplemented with 1mg/l stigmasterol, and Na2HPO4∙7H2O. The medium
was inoculated with Klebsiela pneumoniae 24 hours before addition of P.
tetraurelia. The cells were cleaned for 1 hour in 10 ml of Dryl’s solution (1 mM
NaH2PO4∙H2O, 1 mM Na2HPO4∙7H2O, 2 mM sodium acetate, 1.5 mM CaCl2,
pH6.8) with 100 l of gentamicin reagent solution and transferred into a new
inoculated 1.5 l of ―Improved‖ wheat medium (wheat grass medium
supplemented with 0.67 g/l protease peptone, Na2HPO3, NaH2PO3, and Tris-HCl
to buffer pH). The cells were grown at 28 C until in logarithmic phase.

Crude pellicle preparation: Cells from 6 liters of ―Improved‖ wheat grass
medium were harvested by filtering the medium through Kimwipes tissue paper
and cheesecloth and concentrated by centrifugation at 820xg in the IECCLINICAL continuous flowing centrifuge (Chemical Model) and pelleted by
centrifugation at 350xg for 2 minutes in pear-shaped centrifuge tubes (IEC HNDII centrifuge). The cell pellet was washed twice by centrifugation for 2 minutes
in 125 ml ice-cold HM (homogenization) buffer (20 mM Tris-base, 20 mM Maleic
acid, and 1 mM Na2EDTA pH 7.8). The cell pellet was washed one more time in
125 ml freshly prepared HMI buffer (HM buffer with protease inhibitors, 1.25 ml of
10 mM phenylmethylsulfonyl fluoride (PMSF), 1.25 ml of 100 mM iodoacetic acid,
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125 l of 1 g/ml leupeptin, 125 l of 1 g/ml pepstatin). After centrifugation, the
cell pellet was transferred to a cold 15 ml Potter/Elvehjem homogenizer. The
cells were homogenized with the pestle in an electric drill chuck to deciliate and
rupture the cells. Cell disruption was checked using phase-contrast microscopy
and continued until more than 75% of the cells were ruptured. The homogenate
was centrifuged at 3440xg for 5 minutes at 4 C in JA-17 rotor (Beckman J2-21
centrifuge). The pellet was washed with ice-cold HMI buffer by vigorous mixing
for 30 seconds and centrifuged at the same condition to discard the supernatant.
The washes and centrifugation were repeated for 6-8 times until the supernatant
was clear. After last wash, the pellet was resuspended in 2 ml membrane buffer
(50 mM Tris, 50 mM KCl, 5 mM MgCl2, 1 mM EGTA, pH 7.4) with protease
inhibitors. The protein concentration of the pellicle preparation was measured
with Micro BCA Protein Assay (Pierce) using bovine serum albumin as standard.

Sodium Carbonate Extraction of Pellicle Proteins: Pellicle preparations (500
g) were suspended in 1 ml 0.1 M Na2CO3 (pH11.5) and rocked at 4 C for 1 hour.
The sample was centrifuged at 13,100xg at 4 C for 8 minutes (Eppendorf
centrifuge 5415c) to pellet the protein. The pellet was resuspended in one
volume of 2x SDS/sample buffer (0.5 M Tris-HCl, 20% glycerol, 4% SDS, 0.2 M
DTT, 0.001% bromophenol blue, pH 6.8) and analyzed by SDS-PAGE and
Western blotting.
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Triton X-100 Solubilization of Pellicle Proteins: The crude pellicle preparation
(20 mg) was suspended in 4 ml membrane buffer with 80 l Triton X-100 (final
concentration 1%) and protease inhibitors (0.04 ml of 10 mM
phenylmethylsulfonyl fluoride (PMSF), 0.04 ml of 100 mM iodoacetic acid, 40 l
of 1 g/ml leupeptin, 40 l of 1 g/ml pepstatin) and solubilized at 4 C with
rocking for 1 hour. The solubilized pellicle preparation was centrifuged at
29,400xg for 10 minutes at 4 C in a J-17 rotor (Beckman J2-21 centrifuge) to
obtain the Triton X-100-insoluble pellet that was used in lipid rafts analysis. The
solubilized proteins in the supernatant were precipitated by one volume of cold
100% acetone at 4 C for 15 minutes. The samples were centrifuged at 13,100xg
at 4 C for 10 minutes (Eppenddorf centrifuge 5415c) to pellet the proteins. The
pellet from the supernatant was resuspended in one volume of 2x SDS/sample
buffer and analyzed by SDS/PAGE and Western blotting.

Sucrose gradient centrifugation lipid raft preparation: The Triton X-100insoluble pellet was suspended with 0.5 ml membrane buffer and 1.5 ml ice-cold
80% (w/v) sucrose TNE (10 mM Tris-base, 100 mM NaCl, and 1 mM sodium
EDTA) solution to get a final concentration of 40% (w/v) sucrose in the
suspension. 500 l of this suspension was overlaid with 4 ml 5-40% continuous
linear sucrose gradient, which was made with a continuous gradient maker and a
Buchler Duostaltic pump, in each of six ice-cold 4.5 ml Ultra-clear (11 60 mm)
centrifuge tubes (Beckman). The tubes were balanced by adding 5% sucrose
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TNE solution in the remaining space in the tube. The Ultra-clear tubes were
placed in Beckman SW60 Ti swinging bucket rotor and centrifuged at 160,000xg
at 4 C for 4 hours (Beckman L8-70M Ultracentrifuge). The supernatants from
each of the six Ultra-clear tubes were removed in nine fractions of 500 l each.
The similar fractions from the 6 tubes were pooled together. The 9 fractions were
dialyzed in MilliQ H2O at 4 C for 24 hours, and precipitated in 4 times of the
volume with 100% acetone at -20 C overnight, and centrifuged at 15,200xg at
4 C for 15 minutes in J-17 rotor (Beckman J2-21 centrifuge) to pellet the proteins.
The pellets from each fraction were washed with 90% acetone, kept at 4 C for 10
minutes, and centrifuged again. The supernatants were discarded and the pellets
were air-dried on ice. The pellets were suspended in 50 l membrane buffer and
10 l 6 SDS/sample buffer.

SDS-PAGE Electrophoresis and Western blotting: 7% SDS acrylamide
separating gel or 7%--15% gradient gel, with 3.9% stacking gel was used to
separate proteins. The gels were run at stable current of 30 mA in Hoeffer Might
Small system. All the samples were boiled for 5 minutes before being loaded in
the gel. The gels were transblotted at 250 mA and 390 mA for 45 minutes
respectively onto a nitrocellulose membrane. The membranes were blocked with
5% non-fat dry milk in Tris-Buffer Saline with Tween-20 (TBS-T; 0.16 M Tris-HCl,
0.04 M Tris-base, 1.4 M NaCl and 1% Tween-20 pH7.5) for 1 hour or with
addition of 2% telost gelatin and 3% goat serum in the dry milk TBS-T for 1 hour.
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The blots were probed for the proteins of interest with different primary antibodies
(rabbit anti-surface antigens 1:5,000, rabbit anti-CBD (calmodulin binding domain)
1:5,000, commercial rabbit anti-FBP 1:2,000, rabbit anti-pFBP (Paramecium
folate receptor) 1:10,000, mouse anti-tubulin 1:10,000 or rabbit anti-actin 1:5,000)
overnight. The blots were washed in TBS-T 3 times (15 minutes 1, 5 minutes 3)
and incubated with alkaline phosphatase conjugated secondary antibody (goat
anti-rabbit IgG, Sigma), 1:10,000 diluted in TBS-T. Then the blots were washed
again in TBS-T 3 times (15 minutesx1, 5 minutesx3). Finally, the blots were
developed in 10 ml of nitro-blue tetrazolium/5-bromo-4-chloro-3-indolyl
phosphate (NBT/BCIP).
Some blots were probed using enhanced chemiluminescence (ECL,
Amersham) following the manufacture’s instructions. The blots that were blocked
with 5% non-fat dry milk in TBS-T for 1 hour were probed with primary antibody
of interest (rabbit anti-N terminus of PMCA3 1:5,000 or mouse anti-HA 1:5,000)
overnight. The blots were washed in TBS-T 3 times (15 minutes 1, 5 minutes 3).
The blots were incubated with a suitable secondary antibody (goat anti-rabbit or
goat anti-mouse IgG 1:5,000, Amersham) conjugated with horseradish
peroxidase. The blots were washed again in TBS-T 3 times (15 minutes 1, 5
minutes 3). The blots were incubated in equal volumes of reagent 1 and 2 (ECL
Kit Amersham) for 1 minute. The blots were exposed to films (Kodak BioMax
XAR Film) for 10 seconds to 2 hours. The exposed films were developed in D-19
developer (Kodak) and fixed in rapid fixer (Kodak).
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Stripping and reprobing blots: The blots that had been developed with ECL
were stripped of the primary and secondary antibodies by incubating the blots in
the stripping buffer (Pierce) at 37 C for 45 minutes with rocking. The blots were
rinsed in TBS-T to remove the stripping buffer. Then the blots were blocked,
reprobed with the primary antibody of interest, incubated with alkaline
phosphatase conjugated secondary antibody and developed in NBT/BCIP as
described above.

Overexpression of HA-tagged PMCA2 in transformed cells: The transformed
cell line is a gift from Dr. Junji Yano. The transformed cells containing the HAtagged PMCA2 construct were cultured in wheat grass medium containing 200
g/ml paramomysin at 22 C. The paramomysin can screen the transformed cell
which containing the HA-tagged PMCA2 construct in the macronucleus during
cell division. The transformed cells are harvested and used in pellicle preparation
as described before.

Immunofluorescence Microscopy: Cells were harvested by centrifugation at
350xg for 2 minutes in pear-shaped centrifuge tubes (IEC HN-DII centrifuge).
The cell pellet was washed in 10 ml Dryl’s solution by centrifugation (IECCLINICAL centrifuge Clinical Model) at 1050xg for 2 minutes. Cells were
permeablized in 10 ml PHEM solution (60 mM PIPES, 25 mM Hepes, 10 mM
EGTA, 2 mM MgCl2 and 0.05% Triton X-100) for 5 minutes. Cells were fixed in
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10 ml PBS (1.85 mM NaH2PO4∙H2O, 8.4 mM Na2HPO4, and 150 mM NaCl pH
7.4) containing 2% freshly made paraformaldehyde for 1 hour. Each time cells
were pelleted by centrifugation and the supernatant was discarded. Cells were
washed 3 times by centrifugation in 10 ml blocking solution (PBS containing
10mM EGTA, 2 mM MgCl2, 0.1 Tween-20 and 1% albumin from bovine serum).
Cells were pelleted by centrifugation, resuspended in PBS-T and aliquoted 100 l
each as one sample. Each sample of cells was incubated with the different
primary antibodies (rabbit anti-CBD 1:50, rabbit anti-FBP 1:50, or rabbit anti-AB
1:50 and mouse anti-1D5 1:100) diluted in PBS-T (PBS with 0.1% Tween-20) at
room temperature for 1 hour or at 4°C overnight. Cells were washed 3 times by
centrifugation in 1 ml PBS-T. Cells were incubated with the secondary antibodies
goat anti-rabbit IgG conjugated with Alexa Fluor 488 and goat anti-mouse IgG
conjugated with Alexa Fluor 568 (Molecular Probes) 1:200 diluted in PBS-T at
room temperature for 1 hour. Cells were washed 5 times by centrifugation in 1 ml
PBS-T. Cells that were only incubated with the secondary antibodies (goat antirabbit IgG conjugated with Alexa Fluor 488 and goat anti-mouse IgG conjugated
with Alexa Fluor 568) served as a negative control. Finally each sample of the
immunostained cells were suspended in the 100 l mounting medium (Vector
Shield). 5 l of the cell suspension was put on slide with cover slip on top and
observed under Confocal Microscope or DeltaVision Microscope.
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Antibodies: Anti-CBD is an affinity purified rabbit polyclonal antibody, which is
against KLH peptide (KPSFILELRRGSSLRKK) (Biosource Caramillo, CA). AntiN-terminus 3, a rabbit polyclonal antibody, is made against a GST- fusion protein
with the sequence of MNQSALKTDVNVTVREEEMRLNMGG, which was then
purified to remove anti-GST (Bethyl Lab Montgomery, TX). Anti-1D5, a mouse
monoclonal antibody, is purchased from Synaptic System (Göttingen Germany).
Anti-tubulin, a mouse monoclonal antibody, is purchased from Sigma (St. Louis,
MO). Anti-folate binding protein (FBP), a rabbit polyclonal antibody, is purchased
from Biogenesis (Brentwood, NH). Anti-pFPB, a rabbit polyclonal antibody, is
made against a GST-fusion protein with the sequence of 100 amino acids from
the initiation site of N-terminus of Paramecium folate binding protein (Weeraratne,
2004) by Lampire Biological Lab Inc.(Pipersville, PA). Anti-surface antigens, a
rabbit polyclonal antibody, donated by Dr. Jim Forney, is made against the saltethanol wash proteins of Paramecium, which expresses surface antigen A or B.
Anti-actin is a rabbit polyclonal antibody, donated by Dr. Helmut Plattner.

Sterol Depletion: Cells were harvested and pelleted as described above. The
pelleted cells were incubated in 2mM NaCl chemokinesis buffer (1 mM calcium
citrate, 1 mM Tris-base and 2 mM NaCl pH 7.05) containing 5 mg/ml methyl-βcyclodextrin (MβCD) at 28 C for 2 hours. Cells that were incubated in 2mM NaCl
chemokinesis buffer without MβCD served as a control. Cells were collected and
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used in crude pellicle preparation as described above. The cholesterol levels in
pellicle were measured in cholesterol assay.

Cholesterol Assay: Following the manufacturer’s protocol, 50 l of cholesterol
reference standard with different concentrations (0, 1, 2, 3, 4, 5, 6, 7, 8 g/ml)
were made in 1x Reaction Buffer (Amplex Red Kit, Molecular Probes). 50 l of 10
M hydrogen peroxide served as a positive control. Pellicle containing 60 g
protein diluted in 1x Reaction Buffer to the final volume of 50 l was taken as one
sample. The cholesterol reference standard, the hydrogen peroxide and samples
were loaded in 96-well microtiter plate. The reactions were started by adding 50
l of 300 M Amplex Red Reagent (20 mM Amplex Red reagent, 2 U/ml
Horseradish peroxide, 2 U/ml cholesterol oxidase and, 0.2 U/ml cholesterol
esterase) and incubated at 37°C for 30 minutes protected from light. The data
were collected by a fluorescence microtiter plate reader (wavelength of excitation
at 530 nm, emission at 590 nm). The standard curve was plotted by Microsoft
Excel. The concentrations of cholesterol in each sample were obtained from the
standard curve and equation.

Protein Assay: 100 l of various concentrations (0, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3
mg/ml) of bovine serum albumin (BSA) were made by diluting 2 mg/ml BSA stock
in MilliQ H2O to the final volume of 100 l. Pellicle were 1:10 diluted to the final
volume of 100 l. 2 ml of BCA protein assay reagents A and B at the ratio of
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98(A):2(B) (Pierce) were added to the standards and the samples respectively.
The reactions were incubated at 37°C for 30 minutes. The absorbance of the
reactions was measured at 562 nm in Spectrophotometer (Agilent 8453). The
standard curve was plotted and the protein concentration in samples was
obtained by UV-visible Chemstation Software.

Phosphatase treatment: The crude pellicle was suspended in 1 ml of Tris/MgCl2
Buffer (50 mM Tris∙Cl, 1 mM MgCl2 pH7.5). The protein concentration was
obtained through Protein Assay. 500 ug of protein was taken as a sample and
diluted with Tris/MgCl2 Buffer to a final volume of 250 ul. Samples were
incubated at 30ºC for 15 minutes. 100U or 150U of calf intestine alkaline
phophatase and that are boiled for 5 minutes were added to individual sample
and incubate them at 30ºC for 15 minutes. After incubation, samples were
centrifuged at 13,100xg at 4 C for 10 minutes. Supernatants were discarded. The
phosphate-treated pellicle was extracted by Na2CO3 as described before.

Paramecium Genomic DNA Isolation: Paramecia were grown in 100 ml wheat
grass medium at 28 C till stationary growing phase. Cells were harvested by
filtering through Kimwipes tissue and pelleted by centrifugation at 350xg for 2
minutes in IEC HN-DII centrifuge. Cells were washed twice in 10 ml Dryl’s
solution (1 mM NaH2PO4∙H2O, 1 mM Na2HPO4∙7H2O, 2 mM sodium acetate, 1.5
mM CaCl2, pH6.8). Each time the cells were pelleted by centrifugation at 200xg
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for 2 minutes in the IEC Clinicla Centrifuge. The cell pellet was suspended in 100
l Drl’s solution and transferred into 2 ml Microfuge tube. To the cell suspension,
200 l Denaturing solution (Promega) was added, mixed well by inversion
several times and followed by addition of 30 l 3 mM sodium acetate (pH 5.2),
and mixed well. An equal volume of phenol/chloroform/isoamyalcohol (25:24:1)
was added to the sample, mixed well and kept on ice for 10 minutes. The sample
was centrifuged at 16,000xg for 20 minutes in the Eppenddorf centrifuge 5414C
at 4 C. The aqueous phase (upper layer) was transferred to a new 1.5 ml
Microfuge tube, followed by the addition of same volume of 100% isopropanol
and mixed well. The sample was kept at -20 C for 30 minutes to precipitated
DNA. The sample was centrifuged at 16,000xg for 20 minutes at 4 C to pellet
DNA. The DNA pellet was washed 3 times with 500 l 70% ethyl alcohol. Each
time, the sample was centrifuged at 16,000xg for 5 minutes at 4 C, to discard the
supernatant. The sample was placed in fume hood for 20 minutes to vaporize the
remaining ethanol. The genomic DNA was dissolved in 50 l of sterilized MilliQ
H2O and stored at -20 C for future use. The concentration of the DNA was
measured by using the Nanodrop quantitation (Nanodrop).

Generation of RNAi construct: 1003 and 1002 bases of gene fragments from
the initiation site of ATG of PMCA2 (AY057227) and PMCA3 (AY057226) genes
respectively were amplified by PCR using following primers and gemomic DNA
as template.
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The primers of PMCA2 RNAi construct:
Forward primer: 5’ (+1) ATG TAA TCT CCA AAT AAA AGT GC 3’
Reverse primer: 5’ (+1003) CTG AGA TCA ATC CAA ACT TAC C 3’
The primers of PMCA3 RNAi construct:
Forward primer: 5’ (+1) ATG AAAT CAA TCG GCT TTA AAA AC 3’
Reverse primer: 5’ (+1002) CAC AAT CAA TAT GGC AGC ATA 3’
The PCR was applied under the following condition:
Stage 1: 94 C for 2 minutes; Stage 2: 94 C for 1 minute, 50 C for 2 minutes, and
72 C for 2 minutes, 30 cycles; Stage 3: 72 C for 15 minutes, hold at 4 C.
The amplified PMCA2 or PMCA3 gene fragments were cloned into TOPO
plasmid vector (Invitrogen) and transformed into OneShot chemically competent
cells under the manufacture’s instruction.
The plasmids with insert of PMCA2 or PMCA4 gene fragment were
isolated by using Wizard Plus Mini-Prep Kit (Promega) under the manufacture’s
instruction. The TOPO plasmid with insert was sequence by Vermont Cancer
Center Sequencing Facility.
The TOPO plasmids with the insert were digested with restriction
enzymes Hind III and Xho I (Invitroge) to release the PMCA2 or PMCA3 gene
fragment. At the same time, the Litmus 28i plasmid vector was digested by the
same restriction enzyme to linearize the vector. The products of digested TOPO
plasmids were run in a 1.2% agarose gel to separate the insert of gene fragment
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form the plasmids. The separated gene fragments were purified by using
PerfectPrep Gel Cleanup Kit (Eppendorf) under manufacture’s instruction.
The purified gene fragments were ligated to the linearized Litmus 28i
vector by using the Clonable Ligation 2X Premix (Novagen) following the
manufacture’s instruction. The ligated products were transformed into Ecoli. HT
115 competent cells. The Litmus 28i empty vector was also transformed into
Ecoli. HT115 competent cells to serve as a control. The positive colony was
picked to grow in 5 ml LB culture with 5 μl of 100 g/ml Ampicillin at 37 C
overnight. 275 μl of HT115 cell culture was mixed with 25 μl of sterilized glycerol
to make a glycerol stock that was kept at -80 C for future use.

RNAi Feeding: The 300 l glycerol stocks of HT115 cells with PMCA2 or 3 RNAi
construct or Litmus 28i empty vector were grown in 5 ml LB culture with 5 l of
Ampicillin in the shaking incubator at 37 C overnight. 1 ml of the overnight culture
was added to 50 ml of LB with 50 l of Ampicillin and grown in the shaking
incubator at 37 C. When the O.D.595nm value reached 0.4, the cultures were
induced with 125 l of 50 mg/ml isopropyl-β-D-thiogalactopyranoside, dioxane
free (IPTG) and kept under the same condition. The induced HT115 bacteria
were harvested by centrifugation at 2,200xg for 10 minutes in JA-17 rotor
(Beckman J2-21 centrifuge). The bacterial pellet was suspended in 100 ml
Paramecium wheat grass culture with the100 l of 100 g/ml Ampicillin, 250 l of
50 mg/ml IPTG and 100 l of 8 mg/ml of Stigmasterol. Next, 50 to 100 paramecia
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that were cleaned in Dryl’s solution at room temperature were introduced to the
RNAi cultures grown at 28 C for 72 hours.
Every 24 hours, the supplement of 100 l of 100 g/ml Ampicillin, 250 l
of 50 mg/ml IPTG and 100 l of 8 mg/ml of Stigmasterol was added. After 72hour growth, paramecia were harvested and cleaned in 2mM NaCl chemokinesis
buffer for T-Maze assay.

T-maze Assay: The T-maze assays were performed as previously described
(Van Houten et al., 1982). One arm of the T-maze was filled with 2mM NaCl
chemokinesis buffer as the control arm. The other arm was filed with
chemokinesis buffer with indicated salt solution (2mM Na-glutamate, 2mM Naacetate, 1 mM of Na2-folate or 2mM NH4Cl) as the test arm. Paramecia
containing PMCA2 orPMCA3 RNAi construct or empty Litmus 28i vector were
loaded in the stopcock. The stopcock was turned on allowing paramecia to swim
to each arm. After 30 minutes, the stopcock was closed and the paramecia from
each arm were collected separately. Cells in 1.5 ml of aliquot from each arm
were counted under bright field microscope. The value of Index of
Chemoattraction (I che) was calculated through the formula of Iche= (cell number in
test arm)/ (sum of cell number in both test and control arms). Any I che higher than
0.5 indicates chemoattraction.
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Results
The presence of PMCA in Pellicle
The pellicle proteins from wild type Paramecium were extracted with 0.1
M Na2CO3 and analyzed through 7% SDS-PAGE and Western Blot. An antibody
against the calmodulin-binding domain (CBD) of PMCA2 was used to
immunoprobe the blot. This recognizes three proteins around the region of
molecular weight of 115.5 KD (Fig 1). The calculated molecular weights of the
three bands are 125KD, 113KD, and 106KD. Anti-CBD is an affinity purified
antibody that was generated against the calmoudulin binding domain of PMCA2.
It has been shown that this antibody can recognize the expressed CBD-fusion
protein of PMCA2, 3, and 4 (Gannon-Murakami, 2004). The alignment of CBD
from PMCA2, 3 and 4 is shown in figure 1. We conclude that PMCA2, 3, and 4
are present in pellicle, but it is unknown which band corresponds to which
isoform among PMCA2, 3 and 4.

Determination of PMCA isoform 2
To figure out which of PMCA isoforms correspond to the three protein
bands on the Western blots, transformed cells containing overexpressed HAtagged PMCA2 were used. First, Western blots from the pellicle were
immunoprobed with anti-CBD or anti-HA. One protein band was recognized by
both of these two antibodies respectively at the same molecular weight region
relative to the protein marker 115.5 KD on blot (Fig. 2A). This band corresponded
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to the upper protein band among the three that were recognized by anti-CBD in
wild-type cells. Second, Western blots from the pellicle were immunoprobed by
anti-HA and developed through ECL. One protein band above the 115.5 KD
protein marker was recognized by anti-HA on the ECL film. However, on the ECL
film, anti-HA recognized some proteins at lower molecular weight region. The
same blot was stripped and reprobed by anti-CBD. When the ECL film was
overlaid on the blot, it was clear that the protein band recognized by anti-HA
exactly overlaps that recognized by the anti-CBD (Fig. 2B). It was concluded that
among the three protein bands recognized by anti-CBD, the top one is PMCA2.

Identification of the two lower protein bands
To identify the two lower protein bands, another antibody, anti-N terminus
3 (anti-N3), was used. In similar experiments, the pellicle proteins from wild type
cells on blot were immunoprobed by anti-N3 and developed through ECL. Then
the blot was stripped and reprobed with anti-CBD. The two protein bands
recognized by anti-N3 on the ECL film exactly overlapped the two lower bands
recognized by anti-CBD (Fig. 3A). The antibody of anti-N3 was generated against
the NH2-terminal peptide of PMCA3, which has a high homology with the NH2terminal peptide of PMCA4. The alignment of N-terminal peptide from PMCA3
and PMCA4 is shown in figure 3A. So it is possible that anti-N3 recognized both
PMCA3 and PMCA4.
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The specificity of anti-N3 was also tested through preabsorbing the
antibody with a fusion protein of GST-tagged NH2-terminal peptide of PMCA3. In
similar experiment, the pellicle proteins from wild-type cells on blot were
immuoprobed with the preabsorbed anti-N3 and developed through ECL. On the
ECL film, compared with the control experiment using the mock absorbed anti-N3,
the preabsorbed anti-N3 weakly recognized two protein bands that were strongly
recognized by the mock-absorbed (Fig. 3B). It was concluded that the two lower
protein bands recognized by anti-CBD were PMCA3 or PMCA4.
One possible reason for the two protein bands being recognized by antiN3 could be due to phosphorylation. Two serines in calmodulin-binding domain
of PMCA3 can be phosphorylated by protein kinases (Gannon-Murakami, 2004).
To determine the phosphorylation state, the pellicle proteins were treated with
phosphatase before Na2CO3 extraction. In this experiment, 500 μg pellicle
proteins were treated with 100 Units or 150 Units of calf intestine alkaline
phosphatase. However, anti-N3 still recognized two protein bands in the
phosphatase treated pellicle (Fig. 3C). But a positive control that can confirm that
the phophatase was active in the experiment was lacking. Therefore it is not
possible to conclude that the two protein bands recognized by anti-N3 results
form to phosphorylation.

Localization of PMCAs on cell surface
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The localization of PMCAs was studied by the deconvolution microscopy.
An antibody of anti-1D5, which recognizes tubulin at the ciliary basal body, was
used as a marker (Libusova, 2005). The permeablized wild-type cells were
double immunostained with anti-CBD and anti-1D5. PMCAs, labeled by anti-CBD,
were localized at the bases of cilia on the cell surface (Fig. 4A). PMCAs were
also found localized in cilia, especially at the ciliary tips (Fig. 4B). On the ciliary
tips, PMCAs show a strong expression. There was no staining observed in the
cytoplasm (data not shown).

Triton X-100 solubility studies
The pellicle proteins from wild-type cells were solubilized with 1% Triton
X-100 at 4 C for 1 hour. Both Triton-soluble and insoluble pellicle proteins were
analyzed by SDS-PAGE and Western Blot. The blot was immunoprobed by antiN3 and developed by ECL. After stripping, the blot was reprobed with anti-CBD.
The protein bands (PMCA3 or PMCA4) recognized by anti-N3 on ECL film
appeared in the supernatant (Triton-soluble) fraction. These two bands can
completely overlap those bands recognized by anti-CBD on the blot in the same
fraction. One more protein band (PMCA2) that appeared in the pellet (Tritoninsoluble) fraction was recognized anti-CBD (Fig. 5). It was concluded that
PMCA2 cannot be solubilized by cold Triton X-100 and stays in the insoluble
fraction. But PMCA3 or 4 can be readily solubilized by cold Triton X-100. These
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results implied that PMCA2 may be associated with the cytoskeleton or lipid rafts
or both due to its insolubility in cold Triton X-100.

Analysis of Triton-insoluble pellicle proteins
Proteins that cannot be solubilized by cold detergent may be associated
with lipid rafts. These raft-associated proteins can be recovered by floatation in
sucrose density gradient. To find out whether PMCA2 was associated with lipid
rafts, the Triton-insoluble pellicle proteins were recovered in 5%-40% sucrose
linear gradient through ultracentrifugation. Every 500 μl of supernatant was taken
as one fraction. A total of 9 fractions were taken. Proteins from each fraction
were analyzed through 7%-15% gradients SDS-PAGE and Western Blot. The
blots were cut into several pieces according to the molecular weight and
immunoprobed with several different antibodies. GPI-anchored surface antigens,
that are markers for raft proteins, and Paramecium calmodulin-binding
membrane associated protein (PCM) distributed in all fractions (fraction1-9) (Fig.
6A and Fig. 6C). PMCA2 distributes in fraction 3-8 (Fig. 6B). The blots in figure
6A and 6B were from the same experiment. In this experiment ~29 mg pellicle
proteins were used in the preparation. The blot in figure 6C was from another
experiment. In this experiment, ~30 mg pellicle proteins were used in preparation.
Lipid rafts can be associated with cytoskeleton proteins. To find whether
lipid rafts in Paramecium are associated lipid rafts, some blots were also probed
with antibodies against cytoskeleton proteins. Tubulin distributed in all fractions
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(Fig. 6D) and actin distributes in lower fractions (fraction 6-9) (Fig. 6E). Therefore
GPI-anchored surface antigens, PCM, and PMCA2 were localized in lipid rafts in
Paramecium. Cytoskeleton proteins can be associated with lipid rafts. The blots
in figure 6D and 6E were from the same experiment. In this experiment, ~31 mg
pellicle proteins were used in preparation.

Effects of sterol-depletion on raft-associated proteins
Cholesterol is an essential component of mammalian lipid rafts (Simons,
2000). Reduction of sterol levels can disrupt lipid rafts. Methyl-β-cyclodextrin
(MβCD) is a widely used drug that binds to sterols (including cholesterol) and
sequesters them out of membrane to decrease the cholesterol level. To reduce
the cholesterol level in Paramecium, cells were treated with 5mM MβCD at 28 C
for 2 hours. After treatment, the cholesterol level from pellicle was measured in
cholesterol assay. Compared with mock treated (control) cells, the cholesterol
level in the pellicle of MβCD treated cells was reduced by 42 + 1.4 percent (Fig.
7).
To figure out the effects of sterol-depletion on raft-associated proteins,
the pellicle proteins from MβCD treated cells were also analyzed through sucrose
density gradient ultracentrifugation. The distribution of GPI-anchored surface
antigens was limited to fraction 6 to 9 (Fig. 8A). The distribution of PMCA2 was
completely disrupted. PMCA2 was not in the sucrose gradient fractions (Fig. 8B).
The proteins in the pellet (fraction 10) after sucrose gradient ultracentrifugation
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were also analyzed by Western Blot. Surface antigens were present in the pellet
(fraction 10) of both mock treated cells or MβCD treated cells after sucrose
gradient ultracentrifugation (Fig. 8G). Surprisingly, PMCA2 was not present in the
pellet (fraction 10) of either mock treated cells or MβCD treated cells (Fig. 8F).
However, PMCA2 was still present in the pellicle from the MβCD treated cells
(Fig. 9A). In addition, MβCD treatment had no effect on the detergent-solubility of
PMCA2 or another GPI-anchored protein of folate receptors. PMCA2 and GPIanchored folate receptors were still Triton-insoluble and stayed in the pellet
fraction (Fig. 9B). Interestingly, PCM still distributed in all fractions from 1 to 10
(Fig. 8C). MβCD treatment did not affect the distribution of PCM in sucrose
gradient fractions. Similar to the GPI-anchored surface antigens, the distribution
of tubulin was also restricted to lower sucrose gradient fractions (fraction6-9) (Fig.
8D). The distribution of actin in sucrose gradient was slightly changed into
fraction 7-9 (Fig. 8E). The blots from figure 8A and 8B were from one experiment.
In this experiment, ~32 mg pellicle proteins were used in preparation. The blot in
figure 8C was from another experiment. In this experiment, ~28 mg pellicle
proteins were used in preparation. The blots in figure 8D and 8E were from same
experiment. In this experiment, ~33 mg pellicle proteins were obtained in
preparation.
The effects of MβCD treatment on the localization of GPI-anchored
surface antigens and PMCAs in permeablized cells were studied by
deconvolution immunomicroscopy. It was found that GPI-anchored surface
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antigens were localized at the bases of cilia on the cell surface. MβCD treatment
affects their localization pattern (Fig. 10A). In the MβCD treated cells, GPIanchored surface antigens were still on the cell surface membrane, but the
ciliary-base staining pattern was disrupted. In the MβCD treated cells, GPIanchored surface antigens were not localized at the bases of cilia. Similarly,
PMCAs were also localized at the bases of cilia on the cell surface. MβCD
treatment dramatically disrupted the ciliary base-localization of PMCAs. PMCAs
distributed across the surface membrane (Fig. 10B).
In addition, in the unpermeablized mock treated cells, surface antigen
immunostaining showed a different pattern. Surface antigens were localized on
the ridge of the cortical units on cell surface (Fig. 10C). The cortical unit was a
parallelogram pattern with delineated ridges which consists of plasma membrane,
alveolar sacs and epiplasmic layers (Hufnagel, 1969). However, in the
unpermeablized MβCD treated cells, the cortical unit-stain pattern showed a
typical change (Fig. 10C). Surface antigens showed a plaque-staining pattern on
the cell surface membrane.

Chemoattraction studies of RNAi treated cells
RNAi feeding method was applied to down-regulate PMCA2 or PMCA3 in
Paramecium. Unfortunately, both RNAi-PMCA2 and RNAi-PMCA3 cells had no
detectable reduction at mRNA level or protein level of PMCA2 and PMCA3 (data
not shown). But their chemoattractions were still studied in T-Maze assays.
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Compared with control cells, both RNAi-PMCA2 and RNAi-PMCA3 cells showed
decreased chemoattraction toward glutamate only. No change was seen toward
other attractants (Table 1).

Chemoattraction studies of MβCD treated cells
The effect of MβCD treatment on chemoattraction of Paramecium was
studied in T-Maze assays. MβCD treatment decreased the chemoattraction
toward glutamate. Unexpectedly, the MβCD treated cells showed a
chemorepulsion to cAMP compared with the chemoattraction of control cells
toward cAMP (Table 2).
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Discussion
The presence of PMCAs in pellicle
The pellicle is a membrane structure, consisting of plasma membrane,
tightly associated alveolar sacs and an epiplasmic layer. A putative Ca2+transporting ATPase possessing properties of PMCAs was first biochemically
characterized in the pellicle of Paramecium (Wright, 1990). Wright reported that
The Ca2+-ATPase activity is predominantly in plasma membrane, not in cilia. In
current work, we show that PMCAs are present in pellicle through fractionation
and Western Blot analysis of pellicle proteins. Recently it was reported that
PMCAs were present in cilia through the Western blot analysis of ciliary proteins
(Ray, personal communications). These results are supported by our
immunomicroscopy studies, in which, immunolabled PMCAs were present in cilia.
An antibody anti-CBD was used in both Western Blot analysis and
immunomicroscopy studies. Anti-CBD is an affinity-purified antibody that is
generated by against the calmodulin-binding domain (CBD) of PMCA2.
With Western blot anti-CBD recognizes three protein bands. In
immunostaining images, this antibody labels PMCAs on the surface membrane
and cilia. On the cell surface PMCAs are localized at the base of cilia. Although
anti-CBD is against CBD of PMCA2, it can also recognize CBD of PMCA3 and
PMCA4 (Gannon-Murakami, 2005). So, it is not surprising that anti-CBD
recognizes three protein bands. The calculated molecular weights of these three
bands based on their mobility on the gel are125KD, 113KD and 106 KD. These
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three bands may represent PMCA2, 3 and 4. On the blot, the molecular weight of
three bands is around 115.5 KD, which is a little different from the calculated
molecular weight based on the putative protein sequence (PMCA2 129 KD;
PMCA3 and PMCA4 125 KD). But it is usual that the mobility of protein on SDSPAGE does not show the exact molecular weight due to numerous factors such
as gel concentration, the amount protein loaded, and denaturing degree.

Identification of three PMCA isoforms
Since three PMCA isoforms are recognized by anti-CBD in Western Blot,
we tried to determine which isoform each protein band represents.
Overexpression of HA-tagged PMCA2 in transformed cell was used to identify
PMCA2. Interestingly, overexpression of one isoform (PMCA2) can affect the
expression of the other two isoforms (PMCA3 and PMCA4) (Dr. Yano, personal
communication). So in the Western Blot analysis of pellicle proteins from
transformed cells, anti-CBD and anti-HA both recognize the same protein band,
which is the highest molecular weight band among the three protein bands
according to the molecular weight marker. So it is concluded that the upper
protein bands among those three represents PMCA2.
To determine the presence of the PMCA3, another antibody, anti-N3 was
used in Western Blot analysis. This antibody is generated against the N-terminal
peptide of PMCA3, but recognizes two lower proteins bands. The specificity of
anti-N3 is tested by absorbing the antibody with a fusion protein of GST-tagged
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N-terminal peptide of PMCA3. In the test, anti-N3 shows a high specificity of the
two lower protein bands. One explanation of these two bands is due to
phosphorylation, because it has been found that two serines in CBD of PMCA3
are the substrates of protein kinases. But this possibility can be ruled out by the
phosphatase treatment. Anti-N3 still recognizes two lower protein bands in the
phosphatase-treated pellicle. But one limit of this experiment is that there is no
positive control to confirm the phosphatase is active in the experiment. However,
it is found that N-terminal peptides of PMCA3 and PMCA4 share a high
homology. In addition, anti-N3 is generated against the N-terminal peptide of
PMCA3. So it is possible that anti-N3 recognizes both PMCA3 and PMCA4.

Down-regulation of PMCA2 or PMCA3
It has been demonstrated that during chemoattraction, the
hyperpolarization of membrane potential is sustained by the activation of PMCAs
to generate the hyperpolarizing conductance (Van Houten, 1998). So the effects
of down-regulation of PMCA2 or PMCA3 were studied for their effects in
attraction. RNAi feeding method was applied to down-regulate the expression
level of PMCA2 or PMCA3. Unfortunately, there were no detectable changes of
either mRNA level or protein level. This may be due the high message level of
PMCA2 or 3, and the introduced siRNA cannot degrade the target mRNA
efficiently. But PMCA2 or PMCA3 RNAi fed cells show a decreased
chemoattraction toward glutamate, and no effect on other attractant. One
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phenomenon of siRNA, called off-target effect, may be the explanation for the
change in chemoattraction. The off-target effect is that the siRNA binds to
unspecific mRNA targets through partial complementarity and causes the mRNA
degradation and the protein expression level decrease. This off target effect can
also result in phenotype change (Jackson et al., 2006). In this case the siRNA
does not bind to the target mRNA (transcript of PMCA2 or PMCA3), but binds to
mRNAs of other proteins, one of which is likely one component of glutamate
chemoattraction signal transduction.

The association of PMCA2 with lipid rafts
More and more signaling molecules, such as receptor proteins and their
effector proteins, have been found preferentially localized into lipid rafts. These
proteins use lipid rafts as platforms to assemble into signal transduction
complexes and work efficiently. Lipid rafts can also regulate signal transduction
through recruiting or expelling signaling components. In this work, it is
demonstrated that PMCA2 is localized in lipid rafts, but PMCA3 or PMCA4 are
not. The raft-association of PMCA2 is highly dependent on the sterol content in
cell membrane as shown by MβCD treatment which disrupts the distribution of
PMCA2 in sucrose gradient and alters localization at the ciliary bases. MβCD
treated cells also show a decreased chemoattraction toward glutamate. In
addition, after the MβCD treatment PMCA2 is not present in the pellet (fraction
10) in the sucrose gradient ultracentrifugation, since there are no proteins can be
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recognized by anti-CBD around the region of 115.5 KD. This result is different
from the theoretical postulation that if PMCA2 does not distribute in the sucrose
gradient, it should stay in the pellet (fraction 10) after the sucrose gradient
ultracentrifugation. It may be due to the mechanical damage on the epitope of
PMCA2 in the sucrose gradient ultracentrifugation. But in the Na 2CO3 extraction,
PMCA2 still stay in the pellicle.
It has been reported that the raft-association of PMCA can be isoform
specific, and certain isoforms may play specific roles in cells. In cerebellum
membrane, only PMCA4 is associated with lipid rafts (Sepulveda, 2006). In hair
bundle cells, PMCA2 continuously extrudes Ca2+ resulting in a localized high
extracellular Ca2+ environment to maintain the inside-negative membrane
potential (Prasad, 2004). Our data suggests that PMCA2 may serve specifically
in glutamate chemoattraction signal transduction to hyperpolarize the membrane
potential. Its association with lipid rafts helps PMCA2 fulfill the role.

Lipid rafts in Paramecium
Lipid rafts have been previously characterized in Paramecium (Chandran,
2004). Raft-associated proteins can be recovered in sucrose density gradient
through ultracentrifugation. This traditional method was applied to analyze the
pellicle proteins in Paramecium. Besides PMCA2, GPI-anchored surface
antigens and PCM are also localized in lipid rafts. In sucrose density gradient,
these two proteins distribute across all the factions. They can serve as raft-
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marker proteins in studies. It has been reported that some lipid rafts are
associated with cytoskeleton proteins. The cytoskeleton-associated lipid raft is
termed detergent-resistant membrane with high buoyant density (DRM-H) (Nebl
et al., 2002). In Paramecium, lipid rafts are also associated with cytoskeleton
proteins. It is found that tubulin distributes across all the fractions. Actin
distributes in fraction 6 to 9. These results imply that in Paramecium,
cytoskeleton proteins participate in stabilizing lipid rafts.
MβCD treatment shows different effects on these raft-associated proteins.
After MβCD treatment, the distribution of GPI-anchored surface antigens and
tubulin appear only in high buoyant density fractions in sucrose gradient. PMCA2
does not show up in the sucrose gradient at all, but the distribution of PCM is not
affected by MβCD treatment. So MβCD treatment does not affect the
distributions of every raft proteins in sucrose gradients. These results indicate
that in Paramecium, lipid rafts may fall into two types, MβCD sensitive or
insensitive. The stabilization of MβCD-sensitive rafts is highly dependent on
cholesterol level in membrane. Any change of cholesterol can disrupt this type of
lipid rafts. In Paramecium, MβCD treatment can cause about 40% decrease of
cholesterol in pellicle. PMCA2 may exclusively localize in the MβCD-sensitive
lipid rafts. MβCD treatment can disrupt the distribution of PMCA2 in sucrose
density gradients and the ciliary base-localization on cell surface. In addition,
cAMP receptor or its effector may be localized in the MβCD-sensitive lipid rafts
too, since in chemoattraction studies, MβCD-treated cells show chemorepulsion

68

to cAMP. The MβCD-insensitive lipid rafts may have a high level of GM1
ganglioside, which can compensate the reduction of cholesterol to preserve the
lipid rafts (Jiang et al., 2007). PCM may be localized in the MβCD-insensitive lipid
rafts. MβCD treated cells show no effect on the folate chemoattraction, so the
GPI-anchored folate receptor may be localized in this type too. GPI-anchored
surface antigens and tubulin may be localized in both types of rafts, as their
distribution in sucrose gradient is partially affected by MβCD treatment.

Summary
In this research, PMCA isoform 2 is identified in Western Blot analysis of
pellicle proteins. Further, it is determine that PMCA2 is associated with lipid rafts.
It is also found that GPI-anchored surface antigens and PCM are localized in lipid
rafts too. Lipid rafts are attached with cytoskeleton proteins including tubulin and
actin. Based on the results of effects of MβCD treatment on raft-associated
proteins, it is proposed that in Paramecium, there are two types of rafts, MβCD
sensitive or insensitive. The effect of PMCA2 in chemoattraction toward
glutamate may highly depend on its association with MβCD sensitive lipid rafts.
Paramecium may utilize these two types of lipid rafts to recruit signaling
molecules with different properties to regulate the chemoattraction signal
transduction tightly. Based on the previous and current results, a working model
of membrane domains incorporating three signal transduction pathways is
proposed (Fig.11). In this model, in pathway 1, glutamate is the only attractant.
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After glutamate binds to its receptor, adenylyl cyclase and a K + channel are
activated. Adenylyl cyclase converts ATP into cAMP, which consequently
activates PKA. PKA can activate raft-associated PMCA2 to generate the
sustained hyperpolarization conductance. In pathway 2, the attractants are more
numerous including cAMP, folate, and acetate. The signaling components in this
pathway are still not clarified. In this pathway, the non raft-associated PMCA(s)
may be activated to generate the sustained hyperpolarization conductance. In
the pathway 3, there are two equilibria of NH4Cl. At extracellular side, NH3
diffuses across the membrane. At the intracellular side, the alkaline pH activates
an unknown cation channel. The efflux of cation generates the hyperpolarization
conductance.
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Chapter 3

Future Directions
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In Paramecium, PMCAs are localized in the pellicle, especially at bases
of cilia. PMCA2 is insoluble in cold Triton X-100, but PMCA3 and/or PMCA4 is
soluble in cold Triton X-100. These results imply that PMCA2 may be associated
with cytoskeleton or present in lipid rafts or both; PMCA3 and PMCA4 may not
be present in lipid rafts or associated lipid rafts. In the lipid raft analysis of pellicle
proteins, PMCA2 may be present in MβCD sensitive lipid rafts. PCM may be
present in MβCD insensitive lipid rafts. GPI-anchored surface antigens may be
present in both MβCD sensitive and insensitive lipid rafts. Lipid rafts in
Paramecium are associated with cytoskeleton proteins such as tubulin and actin.
Sterol-depletion disrupts the localization localization of surface antigens and
PMCAs to bases of cilia. It also disrupts the distribution of PMCA2 in the sucrose
gradients, but has effect on the distribution of PCM in the sucrose gradients.
Sterol-depletion disrupts the chmoattraction to glutamate and cAMP. RNAiPMCA2 and RNAi-PMCA3 transformed cells show reduced chemoattraction to
glutamate.
In the further studies, the localization of PMCA3 and PMCA4 need to be
identified. Generation of isoform specific antibodies would be helpful in this work.
Anti-N3 recognizes two protein bands on the blots. This could be due to the
protein kinase phosphorylation. To figure out this problem, in the experiment of
phosphatase treatment, one positive control is needed to prove that the
phospatase is active in the experimental system. Additionally, the three protein

72

bands that are recognized by anti-CBD can be analyzed in Mass Spectrometry to
support the findings. After MβCD treatment, PMCA2 is still Triton insoluble. It
implies that PMCA2 may be associated with cytoskeleton proteins. The PMCA2
protein interaction partner may be important in PMCA2 raft-targeting, furthermore,
makes PMCA2 serve in a specific signal transduction pathway such as glutamate
pathway in chemoattraction. PMCA3 and/or PMCA4 are not associated in lipid
rafts. These two isoforms may serve in raft-independent signal transductions in
chemoattraction. It is interesting to study the raft-associated and non-raftassociated PMCAs in chemoatraction to clarify the role of lipid rafts in the
chemosensory signal transductions. Additionally, 20 more PMCA isoform genes
are found in annotated Paramecium genome. These results imply that PMCA
isoforms may serve different physiological roles in Paramecium. It is significant to
find out that the specific roles of these 23 PMCA isoforms in Paramecium. Since
RNAi-PMCA2 and RNAi-PMCA3 transformed cells show reduced
chemoattraction to glutamate, but there were no detectable change at both
mRNA and protein level of PMCA2 or PMCA3. A more specific and efficient
siRNA constructing would be very helpful in the studies of the roles of 23 PMCA
isoforms in Paramecium. Beside PMCA2, some receptors and their down-stream
effectors may partition in to lipid rafts. cAMP receptor may be a possible
candidate to be studied, because MβCD treatment dramatically disrupted
chemoattraction toward cAMP. GPI-anchored folate receptor has been
characterized in Paramecium (Weeraratne, 2004). GPI-anchored proteins are
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preferentially localized in lipid rafts. So Paramecium folate receptor can be
another candidate for studying lipid rafts function in chemoattraction. Finally, it is
important to find out the link between surface receptors and PMCAs in signal
transduction. There may be several components between receptors and effectors.
Like in pathway 1, after glutamate binds to its receptor, adenylyl cyclase may be
activated. This membrane-bound adenylyl cyclase may also be associated lipid
rafts to serve in the glutamate signal transduction pathway. To clarify each
component in the signal transduction pathways can be helpful to understand the
signal transuding mechanisms in chemoattraction.
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Figure 1: The presence of PMCA in pellicle proteins.
The pellicle proteins from wild type cells were extracted by 0.1 M Na 2CO3 and
analyzed through Western Blot. The blot was immunoprobed by anti-CBD
(Primary, 1:5,000) and alkaline phosphatase conjugated rabbit anti-IgG
(Secondary, 1:10,000)
Blue arrows point molecular weight. Black arrows point proteins.
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Figure 2: Determination of PMCA isoform 2.
The pellicle proteins from transformed cells containing HA-tagged PMCA2 are
analyzed through Western Blot.
A, Left, the blot was immunoprobed by anti-CBD (primary, 1:5,000). Right, the
bolt wass immunoprobed by anti-HA (primary, 1:5.000). The secondary antibody
of alkaline phosphatase conjugated goat anti-rabbit IgG was diluted 1:10,000.
B, Left. The blot was immunoprobed by anti-HA (primary, 1:5,000) and
horseradish peroxidase conjugated goat anti-rabbit IgG (secondary 1:5,000
diluted) and developed through ECL. Middle, The blot was stripped and reprobed
by anti-CBD (primary, 1:5,000) and alkaline phosphatase conjugated goat antirabbit IgG (secondary, 1:10,000). Right, The ECL film was overlaid on the blot.
Blue arrows point molecular weight. Black arrows point proteins.
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Figure 3: Identification of two lower protein bands.
A. The pellicle proteins from wild type cells were analyzed through Western Blot.
Left, the blot is immunoprobed by anti-N3 (primary, 1:5,000) and horseradish
peroxidase conjugated goat anti-rabbit IgG (secondary 1:5,000) and
developed by ECL. Middle, The bolt was stripped and reprobed by anti-CBD
(primary, 1:5,000 diluted) and alkaline phosphatase conjugated goat antirabbit IgG (secondary, 1:10,000). Right, The ECL film was overlaid on the blot.
B. The specificity test of anti-N3. Left, the blot was immunoprobed by intact antiN3. Right, the blot was immunoprobed by the preaborbed anti-N3.
C. The pellicle proteins were treated by phosphatase, and analyzed through
Western Blot. The blot was immunoprobed by anti-N3 and (primary, 1:5,000)
and horseradish peroxidase conjugated goat anti-rabbit IgG (secondary
1:5,000) and developed by ECL. Lane1, control, no phosphatase. Lane 2, 100
Units phosphatase. Lane 3, 150 Units phosphatase. Lane 4, 100 Units
phosphatase boiled for 5 minutes. Lane 5, 150 Units phosphatase boiled for 5
minutes.
Blue arrows point molecular weight. Black arrows point proteins.
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Figure 4: Localization of PMCAs.
A. Cell surface was labeled by anti-CBD (1: 50). PMCAs are localized to the
bases of cilia.
B. Cilia were labeled by anti-CBD (1:50).
Anti-1D5 (1:100) that labels tubulin at basal body is used as a marker
Images were taken under the objective lens with 60X magnification.
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Figure 5: Trinton X-100 solubility study of PMCAs.
Pellicle proteins (500 ug) were solubilized by 1% triton X-100 at 4 C for 1 hour.
Left. The blot was immunoprobed by anti-N3 (primary, 1:5,000) and horseradish
peroxidase conjugated goat anti-rabbit IgG (secondary 1:5,000 diluted) and
developed by ECL. Right. After being stripped, the blot was reprobed by antiCBD (primary, 1:5,000) and alkaline phosphatase conjugated goat anti-rabbit IgG
(secondary, 1:10,000) and developed by NBT/BCIP.
Blue arrows point molecular weight. Black arrows point proteins.
P: Triton insoluble; S: Triton soluble.
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Figure 6: Distributions of pellicle proteins in sucrose density gradient.
The pellicle proteins (~30 mg) were extracted with 1% Triton X-100 and
recovered in 5%-40% linear sucrose density gradient. Lane 1-9 represents 9
factions of sucrose density gradient. Lane M is protein marker.
A. The blot was immunoprobed by anti-surface antiges (1:5,000 diluted). GPIanchored surface antigens (220-250 KD) distributed in all 9 fractions.
B. The blot was immunoprobed by anti-CBD (1:5,000). PMCA2 (125 KD)
distributes in fraction 3 to 8.
C. The blot was immnoprobed by commercial anti-FBP (1:2,000). PCM (65 KD)
distribute in all 9 fractions.
D. The blot was immnoprobed by anti-tubulin (1:10,000diluted). Tubulin (54 KD)
distributes all 9 fractions.
E. The blot was immnoprobed by anti-anctin, Actin (40 and 43 KD) distribute in
fraction 6 to 9.
Blue arrows point molecular weight. Black arrows point proteins.
The blots represent 2—4 experiments.
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Figure 7: Sterol depletion in pellicle.
The cholesterol level in pellicle was measured through cholesterol assays. The
cholesterol level in pellicle from MβCD treated and mock treated cells were
compared. The value is average of 3 measurements.
Cholesterol level in MβCD treated cells shows 42%+1.4 decrease compared with
mock treated cells.
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Figure 8: Distributions of pellicle proteins from MβCD treated cells in
sucrose density gradient.
The pellicle proteins from MβCD treated cells (~30 mg) were extracted with 1%
Triton X-100 and recovered in 5%-40% linear sucrose density gradient. Lane 1-9
represents 9 factions of sucrose density gradient. Lane M is protein marker. Blue
arrows point the molecular weight of protein marker. Black arrows point the
proteins immnunoprobed by different antibodies.
A. The blot was immunoprobed by anti-surface antigens (1:5,000). GPI-anchored
surface antigens on (220-250 KD) distribute in fraction 6 to 9.
B. The blot was immunoprobed by anti-CBD (1:5,000). PMCA2 does not
distribute sucrose density gradient.
C. The blot was immnoprobed by commercial anti-FBP (1:2,000). PCM (65 KD)
distribute in all 9 fractions.
D. The blot was immnoprobed by anti-tubulin (1:10,000). Tubulin (54 KD)
distributes fraction 7 to 9.
E. The blot was immnoprobed by anti-anctin (1:5,000), Actin (40 and 43 KD)
distribute in fraction 7 to 9.
F. The blot was immunoprobed by anti-CBD (1:5,000). PMCA2 is not present in
the pellet (fraction 10) after sucrose gradient ultracentrifugation.
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G. The blot was immunoprobed by anti-surface antigens (1:5,000). Surface
antigens are present in the pellet (fraction 10) after sucrose gradient
ultracentrifugation.
Blue arrows point molecular weight. Black arrows point proteins.
The blots represent 2—4 experiments.
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Figure 9: Western Blot analysis of pellicle proteins from MβCD treated cells.
A. The pellicle protein from MβCD treated and mock treated cells were extracted
by 0.1 M Na2CO3 at 4ºC for 1 hour and analyzed through Western Blot. The
blots are immunoprobed by anti-CBD(Primary, 1:5,000 diluted) and alkaline
phosphatase conjugated rabbit anti-IgG (Secondary, 1:10,000)
B. The pellicle protein from MβCD treated and mock treated cells were
solubilized by 1% Triton X-100, and then analyzed by Western Blot. The Blots
are immnunoprobed by anti-CBD (primary, 1:5,000) or anti-pFBP (primary
1:2,000). The secondary antibody of alkaline phosphatase conjugated goat
anti-rabbit IgG was diluted 1:10,000.
Blue arrows point the molecular weight. Black arrows point the proteins.
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Figure 10: The effects of MβCD treatment on the localization of GPIanchored surface antigens and PMCAs.
A. The cells were permeablized by 0.05% Triton X-100 and double
immunostained by anti-surface antigens (1:100) and anti-1D5 (1:100). In
mock treated cells, GPI-anchored surface antigens are localized at the basis
of cilia. In MβCD treated cells. Their localization pattern is changed.
B. The cells were permeablized by 0.05% Triton X-100 and double
immunostained by anti-CBD (1:50 diluted) and anti-1D5 (1:100). In mock
treated cells, PMCAs were localized at the basis of cilia. In MβCD treated
cells, PMCAs distributed across the cell surface membrane.
Images in A and B were taken under objective lens with 60X magnification.
C. The cells non-permeablized. Both mock and MβCD treated cells were
immunostained by anti-surface antigen A (1:100 diluted). This antibody
labeled the surface antigen on cell surface membrane. But the staining
patterns were different between the mock and MβCD treated cells.
Images in C were taken under objective lens with 100X magnification.
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Table1: Chemoattraction studies of RNAi cells.
The chemoattraction of RNAi cells were studied Through T-Maze assays. The
chemoattractant solutions are 2mM Na-L-glutamate, 2 mM Na-Acetate, 2mM
NH4Cl, 1mM Na2-folate, or 2mM Na-cAMP. The control solution is 2mM NaCl.
The chemoattraction of RNAi cells toward 2mM Na-L-glutamate is statistically
significantly decreased compared with control cells at the P<0.05 level in MannWhitney U test.
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Table 2: Chemoattraction studies of MβCD treated cells.
The chemoattraction of MβCD treated cells are studied through T-Maze. The
chemoattractant solutions are 2mM Na-L-glutamate, 2 mM Na-Acetate, 2mM
NH4Cl, 1mM Na2-folate, or 2mM Na-cAMP. The control solution is 2mM NaCl.
The chemoattraction of MβCD treated cells toward 2mM Na-L-glutamate or 2mM
Na-cAMP are statistically significantly decreased compared with mock treated
cells at P<0.05 level in Mann-Whitney U test. .
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Figure 11: A working Model of 3 signal transduction pathways in
chemoattraction in Parameicum.
In this model, in the pathway 1, glutamate is the only attractant. After glutamate
binds to receptor, adenylyl cyclase and a K+ channel are activated. Adenylyl
cyclase converts ATP into cAMP, which consequently activates PKA. PKA can
activate raft-associated PMCA2 to generate the sustained hyperpolarization
conductance. In the pathway 2, the attractants are more numerous including
cAMP, folate, and acetate. The signaling components in this pathway are still not
clarified. In this pathway, the non raft-associated PMCA(s) may be activated to
generate the sustained hyperpolarization conductance. In the pathway 3, there
are two equilibria of NH4Cl. At extracellular side, NH3 diffuses across the
membrane. At the intracellular side, the alkaline pH activates an unknown cation
channel. The efflux of cation generates the hyperpolarization conductance.
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